Development of a population pharmacokinetics-based sampling schedule to target daily intravenous busulfan for outpatient clinic administration.
about
Pharmacogenetics of intravenous and oral busulfan in hematopoietic cell transplant recipients.A pilot pharmacologic biomarker study of busulfan and fludarabine in hematopoietic cell transplant recipientsBusulfan dosing algorithm and sampling strategy in stem cell transplantation patients.Accurate targeting of daily intravenous busulfan with 8-hour blood sampling in hospitalized adult hematopoietic cell transplant recipientsVariation in prescribing patterns and therapeutic drug monitoring of intravenous busulfan in pediatric hematopoietic cell transplant recipientsBusulfan in infant to adult hematopoietic cell transplant recipients: a population pharmacokinetic model for initial and Bayesian dose personalization.Opportunities for model-based precision dosing in the treatment of sickle cell anemia.Prediction of Intravenous Busulfan Clearance by Endogenous Plasma Biomarkers Using Global Pharmacometabolomics.Physiologically based pharmacokinetic modelling of Busulfan: a new approach to describe and predict the pharmacokinetics in adults.Predictive performance of a physiologically based pharmacokinetic model of busulfan in children.Pharmacokinetics and Pharmacodynamics of Treosulfan in Patients With Thalassemia Major Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.Population pharmacokinetics analysis of intravenous busulfan in Chinese patients undergoing hematopoietic stem cell transplantation.
P2860
Q35053340-9C59899A-FE2C-4A32-AA18-64C0925DA867Q35760706-ECE7504C-817F-461A-98BE-CC080AF9E3ECQ36125427-0B5EE1CD-F6B9-4879-BB5F-00D1D75AE7B5Q37070285-327B79E5-A3B9-4A65-AF4D-ECD1052B9EF4Q37224427-CD30DE34-2794-45DD-99BA-AC68A1BC0009Q37624344-DB157E82-C475-4E93-9FF2-D231EBE5421BQ38642609-57459F63-672E-4443-83F2-E94587463FFDQ41653330-D4C35852-D611-4DB5-B57E-A13AA3A8023EQ44395207-261432A2-B0BC-4456-BF34-3DEB6EF33171Q44419087-D20AF99A-F61A-4B56-80DD-76369975B539Q48106141-D68050D3-CDD2-4522-86D9-C4336B68371BQ50924228-17905F0A-3278-4604-ABB3-B0EE1129A5F2
P2860
Development of a population pharmacokinetics-based sampling schedule to target daily intravenous busulfan for outpatient clinic administration.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Development of a population ph ...... patient clinic administration.
@en
Development of a population ph ...... patient clinic administration.
@nl
type
label
Development of a population ph ...... patient clinic administration.
@en
Development of a population ph ...... patient clinic administration.
@nl
prefLabel
Development of a population ph ...... patient clinic administration.
@en
Development of a population ph ...... patient clinic administration.
@nl
P2093
P2860
P356
P1476
Development of a population ph ...... patient clinic administration.
@en
P2093
David H Salinger
David K Blough
Matthew A Pawlikowski
Paolo Vicini
Paul V O'Donnell
P2860
P304
P356
10.1177/0091270009357430
P577
2010-01-14T00:00:00Z